Update on cervical cancer screening: Current diagnostic and evidence-based management protocols

Postgraduate Medicine

Volumn 113, Issue 2, 2003, Pages 59-70

  Ball, Carol ^a,c   Madden, Joan E ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HEALTHPARTNERS INSTITUTE   (United States)

^c REGIONS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CONFERENCE PAPER; DISEASE SEVERITY; EARLY DIAGNOSIS; EPITHELIUM CELL; EVIDENCE BASED MEDICINE; HUMAN; PAPANICOLAOU TEST; PATIENT CARE; PRACTICE GUIDELINE; SCREENING TEST; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0037331696     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2003.02.1375     Document Type: Conference Paper

References (12)

1. Sawaya GF, Brown AD, Washington AE, et al. Clinical practice: current approaches to cervical-cancer screening. N Engl J Med 2001;344(21):1603-7
2. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132(2):277-84
3. ACOG committee opinion. Recommendations on frequency of Pap test screening. No. 152, March 1995. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995;49(2):210-1
4. US Preventive Services Task Force. Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams and Wilkins, 1996. Available at: http://www.ahrq.gov/clinic/cpsix.htm. Accessed Nov 15, 2002
5. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52(6):342-62
6. Pearce KF, Haefner HK, Sarwar SF, et al. Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med 1996;335(21):1559-62
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1): 12-9
8. Unger ER, Duarte-Franco E. Human papillomaviruses: into the new millennium. Obstet Gynecol Clin North Am 2001;28(4):653-66
9. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Nad Cancer Inst 2001;93(4): 293-9
10. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287(16): 2114-9
11. Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287(16):2120-9
12. Richart RM. A sea change in diagnosing and managing HPV and cervical disease - part 1. Contemp OB/GYN 2002;5:42-56